BiotechTube

S5G4T-1

Phase 3Terminated
0 views this week 0 watching💤 Quiet
Interest: 22/100
22
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Papulopustular Rosacea

Conditions

Papulopustular Rosacea

Trial Timeline

Sep 12, 2018 → Nov 13, 2019

NCT ID
NCT03564145

About S5G4T-1

S5G4T-1 is a phase 3 stage product being developed by Sol-Gel Technologies for Papulopustular Rosacea. The current trial status is terminated. This product is registered under clinical trial identifier NCT03564145. Target conditions include Papulopustular Rosacea.

What happened to similar drugs?

3 of 12 similar drugs in Papulopustular Rosacea were approved

Approved (3) Terminated (0) Active (9)
✅Azelaic acid (Finacea, BAY39-6251) + Metronidazole (Metrogel) + Doxycycline (Oracea)BayerApproved
✅Azelaic Acid foam 15%BayerApproved
✅azelaic acid 15% gel + azelaic acid 15% gelBayerApproved
🔄DFD-29 + Doxycycline + PlaceboDr. Reddy's LaboratoriesPhase 3
🔄DFD-29 + Doxycycline + PlaceboDr. Reddy's LaboratoriesPhase 3
🔄Topical Dapsone 5% Gel + oral antibioticsBristol Myers SquibbPhase 3
🔄Azelaic acid foam, 15% (BAY39-6251) + Vehicle foamBayerPhase 3

Hype Score Breakdown

Clinical
17
Activity
0
Company
5
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT03564145Phase 3Terminated

Competing Products

18 competing products in Papulopustular Rosacea

See all competitors
ProductCompanyStageHype Score
DFD-29 + Doxycycline + PlaceboDr. Reddy's LaboratoriesPhase 3
37
DFD-29 + Doxycycline + PlaceboDr. Reddy's LaboratoriesPhase 3
37
Lotilaner Gel, 2.0%Tarsus PharmaceuticalsPhase 2
29
Deucravacitinib + PlaceboBristol Myers SquibbPhase 2
27
Topical Dapsone 5% Gel + oral antibioticsBristol Myers SquibbPhase 3
40
Azelaic acid (Finacea, BAY39-6251) + Metronidazole (Metrogel) + Doxycycline (Oracea)BayerApproved
40
Azelaic Acid foam 15%BayerApproved
40
Azelaic acid + Vehicle foamBayerPhase 2
32
Azelaic acid foam 15% + Vehicle foamBayerPhase 2
32
azelaic acid 15% gel + azelaic acid 15% gelBayerApproved
40
Azelaic Acid Foam + Azelaic Acid GelBayerPhase 1
26
Azelaic acid foam, 15% (BAY39-6251) + Vehicle foamBayerPhase 3
37
Encapsulated Benzoyl Peroxide CreamSol-Gel TechnologiesPhase 1
19
S5G4T-1 + S5G4T-2Sol-Gel TechnologiesPhase 3
30
S5G4T-1 + S5G4T-2Sol-Gel TechnologiesPhase 3
30
FMX103 minocycline foam 1.5% + Vehicle foamVyne TherapeuticsPhase 3
30
FMX103 1.5%Vyne TherapeuticsPhase 3
30
FMX103 minocycline foam 1.5% + Vehicle foamVyne TherapeuticsPhase 3
30